Obstetrics & Gynecology Doctors in Waterford, MI Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Dr. Richard Ira Ellenbogen, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4000 Highland Road, #120, Waterford, MI 48328 Phone: 248-682-2109    Fax: 248-682-4769

Harvey Lee Raimi, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 950 N Cass Lake Rd Ste 112, Waterford, MI 48328 Phone: 248-683-8050    Fax: 561-994-1296

Dr. Leonard Gordon Dorey, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 25 Pleasant Lake Dr, Waterford, MI 48327 Phone: 248-681-6416    Fax: 248-681-6416

Reda A Khalifa, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3675 Highland Rd, Suite 112, Waterford, MI 48328 Phone: 248-683-8050    Fax: 248-683-8590

Dr. Cara Elizabeth Smith, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5220 Highland Rd Ste 230, Waterford, MI 48327 Phone: 248-456-8001

Dr. Stacy Ann Jenkins, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5220 Highland Rd, Suite 230, Waterford, MI 48327 Phone: 248-618-9400    Fax: 248-618-9490

News Archive

Social determinants of health offer valuable information about a person's heart disease risk

Certain markers of a person's financial and social status, known as social determinants of health, offer valuable information about a person's potential risk of heart disease but are often overlooked, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.

Vizient and Provista insist CMS to reassess approach to Medicare home infusion therapy benefits

Vizient, the largest member-driven health care performance improvement company in the country and its subsidiary Provista, a leading supply chain partner for non-acute health care delivery organizations, urge CMS to reconsider its approach to the Medicare home infusion therapy benefit to recognize the full array of services needed for home infusion therapy services.

Genetic modification of common virus gives extra weapon to kill cancer cells

A common flu virus could be used to overcome patients' resistance to certain cancer drugs - and improve how those drugs kill cancer cells, according to new research from Queen Mary University of London.

Read more Medical News

› Verified 4 days ago